摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3.3.4.4-四氨基苯甲酮 | 5007-67-0

中文名称
3.3.4.4-四氨基苯甲酮
中文别名
3,3',4,4'-四氨基二苯甲酮
英文名称
3,3',4,4'-tetraaminobenzophenone
英文别名
3,3',4,4'-Tetraamino-benzophenon;Methanone, bis(3,4-diaminophenyl)-;bis(3,4-diaminophenyl)methanone
3.3.4.4-四氨基苯甲酮化学式
CAS
5007-67-0
化学式
C13H14N4O
mdl
MFCD00014772
分子量
242.28
InChiKey
NLNRQJQXCQVDQJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    216-218℃
  • 沸点:
    591.1±50.0 °C(Predicted)
  • 密度:
    1.371

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    121
  • 氢给体数:
    4
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2922399090

SDS

SDS:b3dca561cbb8b327a8c22566c61e60ac
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] BI-1H-BENZIMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS<br/>[FR] INHIBITEURS DU VIRUS DE L'HÉPATITE C
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2010017401A1
    公开(公告)日:2010-02-11
    The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    本公开涉及化合物、组合物和治疗丙型肝炎病毒(HCV)感染的方法。还公开了含有这些化合物的药物组合物以及在治疗HCV感染中使用这些化合物的方法。
  • HAIR TREATMENT PRODUCTS COMPRISING POLYMERS
    申请人:Schulze zur Wiesche Erik
    公开号:US20090304620A1
    公开(公告)日:2009-12-10
    The invention relates to hair treatment products, comprising at least one copolymer made of 0.1 to 50% (in relation to the total number of monomers in the copolymer) monomers of the formula (I), wherein the unknowns are defined as in claim 1 , and A2) are monomers from the group of acrylic acid, methacrylic acid and the like, and—optionally non-ionic monomers from the group of acrylamide, vinyl alcohol, and the like, wherein the monomers A2 and A3 together represent 50 to 99.9% (in relation to the total number of monomers in the copolymer) of the copolymer, at least one silicon and at least one selected care product, wherein the products result in advantageous effects for skin and hair.
    该发明涉及头发护理产品,包括至少一种由0.1至50%(相对于共聚物中单体总数的比例)的公式(I)的单体制成的共聚物,其中未知数的定义如权利要求1中定义的,以及A2)是来自丙烯酸、甲基丙烯酸等单体组的单体,以及——可选的非离子单体,来自丙烯酰胺、乙烯醇等单体组,其中单体A2和A3共同代表共聚物中50至99.9%(相对于共聚物中单体总数的比例)的单体,至少含有一种硅和至少一种选定的护理产品,其中这些产品对皮肤和头发具有有利效果。
  • Studies in potential filaricides. 18. Synthesis of 2,2'-disubstituted 5,5'-dibenzimidazolyl ketones and related compounds as potential anthelmintics
    作者:Syed Abuzar、Satyavan Sharma、Nigar Fatma、S. Gupta、P. K. Murthy、J. C. Katiyar、R. K. Chatterjee、A. B. Sen
    DOI:10.1021/jm00157a032
    日期:1986.7
    A series of 2,2'-disubstituted 5,5'-dibenzimidazolyl ketones and related compounds have been synthesized of which 2,2'-bis(carbomethoxyamino)-5,5'-dibenzimidazolyl ketone exhibited a broad spectrum of anthelmintic activity in experimental animals. At doses of 10-50 mg/kg given intraperitoneally, 5 killed 100% of the adult worms of Litomosoides carinii, Dipetalonema viteae, and Brugia malayi. By the
    合成了一系列的2,2'-双取代的5,5'-二苯并咪唑基酮和相关化合物,其中2,2'-双(羰甲氧基氨基)-5,5'-二苯并咪唑基酮在实验中表现出广谱的驱虫活性动物。腹膜内注射剂量为10-50 mg / kg时,有5只可杀死100%的Cartoii Litomosoides,Dipetalonema viteae和Brugia malayi的成虫。通过口服途径,在100-200 mg / kg X 5天时,5的大杀线效率为97-100%。处理过的动物表现出微丝aria逐渐消失,在尸检前它们变成了微丝aria。某些化合物还以50-250 mg / kg的单次口服剂量对大鼠中的人钩虫和and虫,仓鼠中的Ancylostoma ceylanicum和Hymenolepis nana表现出100%的功效。
  • Lightening Agents and/or Dyes that Contain Aldehyde(s)
    申请人:Höffkes Horst
    公开号:US20100278767A1
    公开(公告)日:2010-11-04
    Agents for dyeing and/or lightening keratin fibers, in particular human hair, containing, relative to the weight thereof, 0.001 to 15 wt. % of at least one aldehyde of the formula (I): wherein X represents —CH(R 2 )—SO 2 —Y—R 1 , —CR 3 R 4 R 5 , or wherein Y represents —CH(CHO)— or —CH 2 — or a chemical bond, and wherein each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 independently represents —H or —CN or —F or —Cl or —Br or —I or —CHO or —NH 2 or —NO 2 or —CF 3 or —CCl 3 or —CF 2 CF 3 or —CCl 2 CCl 3 or an optionally substituted (C 1 -C 6 ) alkyl group or a hydroxyalkyl group or a polyhydroxyalkyl group or an optionally substituted (C 1 -C 6 ) alkylene group, and wherein the agent contains no oxidation dye precursors of developer and coupler type.
    含有相对于其重量0.001至15重量%的至少一种醛类化合物的染色和/或漂白角蛋白纤维的制剂,特别是人类头发。其中该醛类化合物的化学式为(I):其中X代表—CH(R2)—SO2—Y—R1,—CR3R4R5,或其中Y代表—CH(CHO)—或—CH2—或化学键,且其中R1、R2、R3、R4、R5、R6、R7、R8、R9和R10独立地代表—H或—CN或—F或—Cl或—Br或—I或—CHO或—NH2或—NO2或—CF3或—CCl3或—CF2CF3或—CCl2CCl3或一个可选择取代的(C1-C6)烷基或一个羟烷基或一个多羟基烷基或一个可选择取代的(C1-C6)亚烷基,且该制剂不含氧化染料的氧化剂和偶联剂类型的前体。
  • Catalytic trimerization of aromatic nitriles and triaryl-s-triazine ring
    申请人:The United States of America as represented by the Administrator,
    公开号:US04159262A1
    公开(公告)日:1979-06-26
    Triazine compounds and cross-linked polymer compositions are made by heating aromatic nitriles to a temperature in the range of from about 100.degree. C. to about 700.degree. C., and preferably in the range of from about 200.degree. C. to about 350.degree. C. in the presence of a catalyst or mixture of catalysts selected from one or more of the following groups: (A) organic sulfonic and sulfinic acids, (B) organic phosphonic and phosphinic acids, and (C) metallic acetylacetonates, at a pressure in the range of from about atmospheric pressure to about 10,000 p.s.i., and preferably in the range of from about 200 p.s.i. to about 750 p.s.i. Aromatic nitrile-modified (terminated and/or appended) imide, benzimidazole, imidazopyrrolone, quinoxaline, and other condensation type prepolymers or their precopolymers are made which are trimerized with or without a filler by the aforementioned catalytic trimerization process into triaryl-s-triazine ring containing or cross-linked polymeric or copolymeric products useful in applications requiring high thermal-oxidative stability and high performance structural properties at elevated temperatures.
    通过在催化剂或多种催化剂的存在下,将芳香族腈加热到约100℃至约700℃的温度范围内,优选在约200℃至约350℃的温度范围内,制备三嗪化合物和交联聚合物组合物。所述催化剂或多种催化剂选自以下一种或多种组:(A)有机磺酸和亚磺酸,(B)有机膦酸和亚膦酸,以及(C)金属丙酮酸盐,在大气压力至约10,000 p.s.i.的压力范围内,优选在约200 p.s.i.至约750 p.s.i.的压力范围内。制备芳香族腈修饰(末端和/或附加)的咪唑、苯并咪唑、咪唑吡啶酮、喹噁啉和其他缩聚型预聚物或其前驱体,这些预聚物通过上述催化三聚化过程与或不与填料三聚化,形成三芳基-s-三嗪环含或交联聚合物或共聚物产品,可用于需要高热氧稳定性和高性能结构特性的应用,如在高温下。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐